Pharmaceutical / Drug Definition :
Reversibly inhibits acetylcholinesterase hydrolysis in CNS, leading to increased acetylcholine level and temporary cognitive improvement in patients with Alzheimer's disease
FDA Label Requirements and Exceptions
Donepezil Hydrochloride
FDA Import Information
Donepezil Hydrochloride
FDA Detentions
Donepezil Hydrochloride (Donepezil Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Donepezil Hydrochloride (Donepezil Hydrochloride Suppliers)
- Processors Donepezil Hydrochloride
- Repackers Donepezil Hydrochloride
- Relabelers Donepezil Hydrochloride
- Exporters Donepezil Hydrochloride
- Importers Donepezil Hydrochloride
For more information about Donepezil Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
